why choose us

Clinical Trials Search

Showing 14,010 of 132,963 result(s)
Brain Health Together: A Live-Streaming Group-Based Digital Program

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: The Brain Health Academy group will review online content about brain health (1 hour, 2 days;week for 12 weeks) and will complete a brief survey

Date: 2023-03-24

Increased Access to Fruits and Vegetables for Hypertension in Immigrant Hispanic;Latinx Individuals

Status: Completed

Condition: Cardiovascular Diseases

Interventions: Weekly food kits including culturally-appropriate fruits and vegetables (to achieve 8-10 servings per day) and staple items to support DASH diet compl

Date: 2023-03-24

Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH)

Status: Completed

Condition: Cardiovascular Diseases

Interventions: The pilot infant CVH intervention will be delivered by Nurse-Family Partnership (NFP) staff starting no later than 1 month postpartum and lasting up t

Date: 2023-03-24

Treating Exacerbations of Asthma With Oral Montelukast in Children

Status: Completed

Condition: Status Asthmaticus

Interventions: Oral montelukast granules, USP powder, or crushed tablets at weight-based doses between 2 mg;kg and 3 mg;kg to a maximum of 180 mg.

Date: 2023-03-24

OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)

Status: Completed

Condition: Dry Eye Syndromes

Interventions: 0.3mg dexamethasone ophthalmic insert

Date: 2023-03-24

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Status: Completed

Condition: Oropharynx Cancer

Interventions: Mon-Fri (5 days for 7 weeks), total 35 fractions over 35 treatment days of radiation therapy (RT)

Date: 2023-03-24

An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

Status: Completed

Condition: ADHD

Interventions: investigational game-play therapy

Date: 2023-03-24

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)

Status: Completed

Condition: Neovascular Age-related Macular Degeneration

Interventions: Single suprachoroidal injection of AXT107 (0.125 mg;eye)

Date: 2023-03-24

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Status: NOT_YET_RECRUITING

Condition: Metastatic Lung Non-Small Cell Carcinoma

Interventions: Undergo blood sample collection

Date: 2023-03-24